
### [NCIT:C6514](http://purl.obolibrary.org/obo/NCIT_C6514)
**Label:** Skeletal Muscle Neoplasm

**Subclasses:** [NCIT:C5525](http://purl.obolibrary.org/obo/NCIT_C5525) (Prostate Embryonal Rhabdomyosarcoma), [NCIT:C6516](http://purl.obolibrary.org/obo/NCIT_C6516) (Malignant Skeletal Muscle Neoplasm), [NCIT:C49166](http://purl.obolibrary.org/obo/NCIT_C49166) (Extracardiac Rhabdomyoma), [NCIT:C6515](http://purl.obolibrary.org/obo/NCIT_C6515) (Benign Skeletal Muscle Neoplasm), [NCIT:C6617](http://purl.obolibrary.org/obo/NCIT_C6617) (Mediastinal Rhabdomyosarcoma), [NCIT:C6517](http://purl.obolibrary.org/obo/NCIT_C6517) (Genital Rhabdomyoma), [NCIT:C5847](http://purl.obolibrary.org/obo/NCIT_C5847) (Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma), [NCIT:C5627](http://purl.obolibrary.org/obo/NCIT_C5627) (Rectal Rhabdomyosarcoma), [NCIT:C5522](http://purl.obolibrary.org/obo/NCIT_C5522) (Prostate Rhabdomyosarcoma), [NCIT:C4258](http://purl.obolibrary.org/obo/NCIT_C4258) (Pleomorphic Rhabdomyosarcoma), [NCIT:C4259](http://purl.obolibrary.org/obo/NCIT_C4259) (Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features), [NCIT:C6378](http://purl.obolibrary.org/obo/NCIT_C6378) (Testicular Rhabdomyosarcoma), [NCIT:C5860](http://purl.obolibrary.org/obo/NCIT_C5860) (Extrahepatic Bile Duct Rhabdomyosarcoma), [NCIT:C5464](http://purl.obolibrary.org/obo/NCIT_C5464) (Central Nervous System Rhabdomyosarcoma), [NCIT:C8971](http://purl.obolibrary.org/obo/NCIT_C8971) (Embryonal Rhabdomyosarcoma), [NCIT:C49204](http://purl.obolibrary.org/obo/NCIT_C49204) (Anaplastic Embryonal Rhabdomyosarcoma), [NCIT:C123735](http://purl.obolibrary.org/obo/NCIT_C123735) (Fusion-Positive Rhabdomyosarcoma), [NCIT:C123736](http://purl.obolibrary.org/obo/NCIT_C123736) (Fusion-Negative Rhabdomyosarcoma), [NCIT:C7000](http://purl.obolibrary.org/obo/NCIT_C7000) (Central Nervous System Rhabdomyoma), [NCIT:C5190](http://purl.obolibrary.org/obo/NCIT_C5190) (Breast Rhabdomyosarcoma), [NCIT:C9130](http://purl.obolibrary.org/obo/NCIT_C9130) (Adult Rhabdomyosarcoma), [NCIT:C123731](http://purl.obolibrary.org/obo/NCIT_C123731) (Fusion-Positive Alveolar Rhabdomyosarcoma), [NCIT:C123732](http://purl.obolibrary.org/obo/NCIT_C123732) (Fusion-Negative Alveolar Rhabdomyosarcoma), [NCIT:C121655](http://purl.obolibrary.org/obo/NCIT_C121655) (Sclerosing Rhabdomyosarcoma), [NCIT:C95623](http://purl.obolibrary.org/obo/NCIT_C95623) (Esophageal Rhabdomyosarcoma), [NCIT:C121654](http://purl.obolibrary.org/obo/NCIT_C121654) (Spindle Cell/Sclerosing Rhabdomyosarcoma), [NCIT:C128048](http://purl.obolibrary.org/obo/NCIT_C128048) (Cervical Rhabdomyosarcoma), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), [NCIT:C27480](http://purl.obolibrary.org/obo/NCIT_C27480) (Classic Rhabdomyoma), [NCIT:C6519](http://purl.obolibrary.org/obo/NCIT_C6519) (Spindle Cell Rhabdomyosarcoma), [NCIT:C3749](http://purl.obolibrary.org/obo/NCIT_C3749) (Alveolar Rhabdomyosarcoma), [NCIT:C5834](http://purl.obolibrary.org/obo/NCIT_C5834) (Liver Rhabdomyosarcoma), [NCIT:C128080](http://purl.obolibrary.org/obo/NCIT_C128080) (Vaginal Rhabdomyosarcoma), [NCIT:C6600](http://purl.obolibrary.org/obo/NCIT_C6600) (Mediastinal Rhabdomyoma), [NCIT:C8824](http://purl.obolibrary.org/obo/NCIT_C8824) (Recurrent Rhabdomyosarcoma), [NCIT:C5236](http://purl.obolibrary.org/obo/NCIT_C5236) (Ovarian Rhabdomyosarcoma), [NCIT:C5610](http://purl.obolibrary.org/obo/NCIT_C5610) (Anal Rhabdomyosarcoma), [NCIT:C3359](http://purl.obolibrary.org/obo/NCIT_C3359) (Rhabdomyosarcoma), [NCIT:C27369](http://purl.obolibrary.org/obo/NCIT_C27369) (Adult Pleomorphic Rhabdomyosarcoma), [NCIT:C4260](http://purl.obolibrary.org/obo/NCIT_C4260) (Fetal Rhabdomyoma), [NCIT:C4261](http://purl.obolibrary.org/obo/NCIT_C4261) (Adult Extracardiac Rhabdomyoma), [NCIT:C45759](http://purl.obolibrary.org/obo/NCIT_C45759) (Cardiac Rhabdomyosarcoma), [NCIT:C5839](http://purl.obolibrary.org/obo/NCIT_C5839) (Gallbladder Rhabdomyosarcoma), [NCIT:C128273](http://purl.obolibrary.org/obo/NCIT_C128273) (Vulvar Alveolar Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma))) 40.36%
- [CL:0000188](http://purl.obolibrary.org/obo/CL_0000188) (cell of skeletal muscle) and (not ([NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma))) 40.36%


